Somatostatin Receptor Positive Neuroendocrine Tumours (NETs) research hub

A Multicentre Surveillance Study to Evaluate the Long-term Safety in Participants who Have Been Previously Treated with 177Lu-IPN01072 in an Ipsen-sponsored Clinical Study

This study looks at the long-term safety of a treatment called 177Lu-IPN01072 for neuroendocrine tumours (NETs). We want to see if people who've had this treatment previously develop any new cancers and track other health changes over time.